Fulgent Genetics (FLGT) Notes Payables (2021 - 2025)
Fulgent Genetics (FLGT) has disclosed Notes Payables for 5 consecutive years, with $476000.0 as the latest value for Q4 2025.
- Quarterly Notes Payables rose 15.53% to $476000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $476000.0 through Dec 2025, up 15.53% year-over-year, with the annual reading at $476000.0 for FY2025, 15.53% up from the prior year.
- Notes Payables hit $476000.0 in Q4 2025 for Fulgent Genetics, roughly flat from $476000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $6.1 million in Q1 2022 to a low of $412000.0 in Q2 2024.
- Historically, Notes Payables has averaged $2.7 million across 5 years, with a median of $1.2 million in 2023.
- Biggest five-year swings in Notes Payables: plummeted 92.64% in 2024 and later rose 15.53% in 2025.
- Year by year, Notes Payables stood at $5.9 million in 2021, then fell by 4.42% to $5.6 million in 2022, then tumbled by 79.02% to $1.2 million in 2023, then plummeted by 65.17% to $412000.0 in 2024, then rose by 15.53% to $476000.0 in 2025.
- Business Quant data shows Notes Payables for FLGT at $476000.0 in Q4 2025, $476000.0 in Q3 2025, and $476000.0 in Q2 2025.